The 3q29 Deletion and 3q29 Duplication: Architecture of Behavioral Phenotypes

Launched by RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY · May 15, 2015

Keywords

ClinConnect Summary

This clinical trial is looking at two related conditions known as 3q29 deletion syndrome and 3q29 duplication syndrome. These conditions happen when a small part of chromosome 3 is either missing (deletion) or extra (duplication). The main goal of the study is to better understand how these genetic changes affect people's health and behavior.

If you or someone in your family has been diagnosed with either of these syndromes, you might be eligible to participate. Participants can include individuals diagnosed with 3q29 deletion or duplication, as well as healthy siblings who are the same age. Parents or guardians will need to give permission for younger participants. During the study, participants will engage in various assessments to help researchers gather important information. It's also important to note that individuals with serious medical conditions that could interfere with the study won't be able to participate. This research aims to improve our understanding and support for those affected by these conditions.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnosis of 3q29 deletion or 3q29 duplication
• • Consent from parents or guardians or an adult with 3q29 deletion or 3q29 duplication that does not require a legal guardian or an adult who is the healthy sibling of an individual with 3q29 deletion or 3q29 duplication or a healthy age-matched control
• Exclusion Criteria:
• • Clinically significant medical disease that would prohibit participation in the study procedures